Search Results for

Clear All Filters

November 18, 2021 | The American Prospect

Hannah Story Brown

Op-Ed

Department of JusticeEthics in GovernmentExecutive BranchIndependent AgenciesRevolving Door

How Biden Can Protect Students From Predatory For-Profit Colleges

The Biden administration inherited a morass of understaffed and undermined federal agencies, weakened by the Trump administration. It makes sense that building back the government’s capacity would be an uphill battle for the Biden administration, with so many years of policymaking undermined by his predecessor. What doesn’t make sense is the jarring number of cases in which the administration is going out of its way, at considerable cost, to uphold Trump-era policies that go against Biden’s stated agenda and the public interest.

October 29, 2021 | The American Prospect

Fatou Ndiaye Toni Aguilar Rosenthal

Op-Ed

Executive BranchPharmaRevolving Door

Will Biden’s FDA Be Led by a Pharma Guy?

Dr. Robert Califf appears to be the clearest front-runner for the (somehow) still open position of commissioner of the Food and Drug Administration. After floating his name in the press a few weeks ago, President Biden recently met with Califf in private. Such meetings tend to be the final step before a nominee is announced.

There’s just one problem: Califf is a longtime political consultant to Big Pharma and, more recently, to Big Tech. In fact, he’s so tied to those industries that he once earned the ire of a certain crucial senator from West Virginia.